149 related articles for article (PubMed ID: 34870316)
21. Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.
Porrello A; Leslie PL; Harrison EB; Gorentla BK; Kattula S; Ghosh SK; Azam SH; Holtzhausen A; Chao YL; Hayward MC; Waugh TA; Bae S; Godfrey V; Randell SH; Oderup C; Makowski L; Weiss J; Wilkerson MD; Hayes DN; Earp HS; Baldwin AS; Wolberg AS; Pecot CV
Nat Commun; 2018 May; 9(1):1988. PubMed ID: 29777108
[TBL] [Abstract][Full Text] [Related]
22. The Current Landscape of Immune Checkpoint Blockade in Metastatic Lung Squamous Cell Carcinoma.
Yuan H; Liu J; Zhang J
Molecules; 2021 Mar; 26(5):. PubMed ID: 33807509
[TBL] [Abstract][Full Text] [Related]
23. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
[No Abstract] [Full Text] [Related]
25. LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA.
Ren P; Xing L; Hong X; Chang L; Zhang H
Cancer Med; 2020 Oct; 9(20):7706-7716. PubMed ID: 32871048
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel immunomodulators in lung squamous cell carcinoma based on transcriptomic data.
Lin X; Li X; Ma B; Hang L
Math Biosci Eng; 2022 Jan; 19(2):1843-1860. PubMed ID: 35135231
[TBL] [Abstract][Full Text] [Related]
27. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
[TBL] [Abstract][Full Text] [Related]
28. CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis.
Wang L; Liu Z; Liu L; Guo C; Jiao D; Li L; Zhao J; Han X; Sun Y
J Cell Mol Med; 2021 Aug; 25(15):7559-7574. PubMed ID: 34288370
[TBL] [Abstract][Full Text] [Related]
29. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
Xu F; Zhang H; Chen J; Lin L; Chen Y
Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
[TBL] [Abstract][Full Text] [Related]
30. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC.
Zhou X; Bao W; Zhang D; Yang Y; Du X; Qiu G
Cancer Biol Ther; 2021 Mar; 22(3):196-203. PubMed ID: 33629937
[TBL] [Abstract][Full Text] [Related]
31. Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
Kim A; Lim SM; Kim JH; Seo JS
Front Immunol; 2021; 12():598671. PubMed ID: 33717076
[TBL] [Abstract][Full Text] [Related]
32. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Wang X; Wang X; Li X; Chang Y
J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
[TBL] [Abstract][Full Text] [Related]
33. Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in
Shi R; Li M; Raghavan V; Tam S; Cabanero M; Pham NA; Shepherd FA; Moghal N; Tsao MS
Clin Cancer Res; 2018 Dec; 24(23):5990-6000. PubMed ID: 30093452
[TBL] [Abstract][Full Text] [Related]
34. NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma.
Brennan K; Shin JH; Tay JK; Prunello M; Gentles AJ; Sunwoo JB; Gevaert O
Sci Rep; 2017 Dec; 7(1):17064. PubMed ID: 29213088
[TBL] [Abstract][Full Text] [Related]
35. PPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model.
Dwyer-Nield LD; McArthur DG; Hudish TM; Hudish LI; Mirita C; Sompel K; Smith AJ; Alavi K; Ghosh M; Merrick DT; Tennis MA; Keith RL
Int J Cancer; 2022 Dec; 151(12):2195-2205. PubMed ID: 35830207
[TBL] [Abstract][Full Text] [Related]
36. An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes.
Liu Z; Deng M; Wu L; Zhang S
Mol Med; 2020 May; 26(1):48. PubMed ID: 32434476
[TBL] [Abstract][Full Text] [Related]
37. Expression of miR-486-5p and its significance in lung squamous cell carcinoma.
Yang S; Sui J; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Aug; 120(8):13912-13923. PubMed ID: 30963622
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
39. Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer.
Ghosh M; Dwyer-Nield LD; Kwon JB; Barthel L; Janssen WJ; Merrick DT; Keith RL
PLoS One; 2015; 10(4):e0122823. PubMed ID: 25860262
[TBL] [Abstract][Full Text] [Related]
40. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
